ABU DHABI, 24th June, 2023 (WAM) — Abu Dhabi Health Services Company, SEHA, a subsidiary of PureHealth, has held its inaugural licensed Best of ASCO UAE 2023 Conference. Organized by Tawam Hospital Abu Dhabi, run by SEHA, the event is the official annual meeting review of the American Society of Clinical Oncology (ASCO), updating healthcare professionals on the latest advances in cancer treatment.
The two-day conference welcomed over 300 registered delegates from the region and beyond, providing attendees with valuable, actionable insights and the opportunity to engage with one of the largest and most diverse audiences in global oncology build connection. The event’s agenda includes presentations on the latest developments in cancer care and highlights the most advanced treatments, products and services in oncology.
Saeed Jaber Al Kuwaiti, SEHA Group CEO, said: “The Best of ASCO UAE 2023 conference will provide an in-depth look at the latest scientific breakthroughs and disruptive advances in the field of cancer treatment. With the expertise of our distinguished faculty, SEHA hopes to evaluate the impact of these findings impact on current standards of care and discover how these remarkable advances are shaping the future of cancer treatment. This is in line with PureHealth’s vision to improve healthcare so people in the UAE can live longer, healthier lives.”
Dr Khalid Balaraj, Director of Oncology Center and Conference Chair, Tawam Hospital, said: “This Medical Oncology Conference has been carefully designed to update clinicians on the latest developments in the field. Our expert faculty will provide an overview of the latest developments and select presentations and discussions The panel will reflect the most important research and strategies in oncology that impact clinical practice and patient care. Participants will have the opportunity to attend in-depth presentations and participate in live panel discussions.”
Home to one of the leading oncology centers in the UAE, Tawam Hospital strives to remain at the forefront of cancer care and research, driven by the latest breakthroughs and approaches. It is operated by SEHA, an independent public joint stock company established to develop the therapeutic activities of Abu Dhabi’s public healthcare system, which owns and operates all public hospitals and clinics in the emirate.
As a subsidiary of PureHealth, one of SEHA’s missions is to raise the benchmark of healthcare excellence, facilitate the development of cutting-edge healthcare solutions, advance the science of longevity, and help people live longer, healthier, happier and more fulfilling lives . As part of PureHealth’s efforts, SEHA is able to leverage technology and engage highly skilled medical, technical and administrative personnel to deliver state-of-the-art healthcare that dramatically improves patient outcomes.